Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes
H A Lee, Sangmo Hong, Cheol‐Young Park, Young Sang Lyu et al.
Journal
Cardiovascular Diabetology
Topics
Diabetes Treatment and Management
article
Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes
H A Lee, Sangmo Hong, Cheol‐Young Park, Young Sang Lyu, Kyung‐Soo Kim
article en
Abstract
No abstract available for this paper.
Publication Tag
Cardiovascular DiabetologyVol. 24(1)
Institutions
Chosun University Hospital (KR), Kangbuk Samsung Hospital (KR), Hanyang University Guri Hospital (KR), CHA University Bundang Medical Center (KR), CHA University (KR), Daewoong Pharmaceutical (South Korea) (KR)
Funders
Dongguk University, Daewoong Pharmaceutical Company
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes — H A Lee, Sangmo Hong, et al. · Cardiovascular Diabetology (2025) | TGRS Research Map | TGRS